Oral flu vaccine on the horizon in Russia
Russian researchers have developed an intranasal influenza vaccine using a novel adjuvant technology, with plans to develop what could become the first tablet flu vaccine formulation.
Archives for January 24, 2007
Patching up Alzheimer's safely
US-based researchers have developed a transdermal vaccine for Alzheimers disease which has been shown to clear brain-damaging amyloid plaques in preclinical studies, offering hope to millions of sufferers worldwide.
QSV inks two clinical trial manufacturing contracts
Canadian contract manufacturer QSV Biologics has signed two manufacturing deals in as many weeks, strengthening its position in the Phase II and III clinical supplies arena.
Disappointing year for Whatman
In a turbulent year, Whatman has failed to meet its projected revenue target by 1-3 per cent and changed its management but resolved litigation that has been hanging over the firm since 2003.
Pharma industry 'growth leaders' in BP and IT outsourcing
More companies in the pharmaceutical industry than any other industry are set to increase their reliance on information technology (IT) and business process (BP) outsourcing this year, new research indicates.
Charles River knuckles down on preclinical biz
Charles River Laboratories confirmed it is persevering in its intention to focus on its preclinical and Phase I businesses while abandoning its late stage development services, during a conference earlier this month.
Outsourcing favoured for Phase IV research
Regardless of internal capacity, the majority of pharma firms are choosing to outsource their Phase IV research.
Test can predict tumour sensitivity to experimental cancer drugs
A new test that predicts if cancer cells are 'primed to die' could be used to guide the development of experimental anti-cancer drugs.
Animal extremist attacks drop
New legislation has helped curb the number of animal rights extremist attacks with fewer companies succumbing to extremist pressure, according to a UK pharmaceutical industry group.
Carbon monoxide: a controlled heart therapy?
Several groups of scientists are developing compounds that slowly release carbon monoxide directly into the bloodstream and that could be used to treat diseases as diverse as high blood pressure, heart disease and cancer.
Bruker brings imaging to the masses
Bruker Daltonics has launched a new technology that could accelerate the use of MALDI imaging in drug discovery labs by simplifying sample preparation procedures.
DHL bags Wyeth logistics contract
Shipping giant DHL has bagged a lucrative contract with pharma giant Wyeth and become the first logistics provider to be given complete responsibility for a company's worldwide clinical trial materials distribution.